Lupin Pharmaceuticals Inc. is recalling 3,552 bottles of Cefixime for Oral Suspension USP 200 mg/5 mL (50 mL pack size). This prescription antibiotic was recalled because it failed content uniformity specifications, which means the concentration of the medication may not be consistent within the bottle or batch. Consumers who have this medication should contact their healthcare provider or pharmacist to discuss their treatment.
Failure to meet content uniformity specifications can result in patients receiving too little or too much of the active medication. Inconsistent dosing could lead to treatment failure or an increased risk of adverse side effects.
You have 2 options:
Recall #: D-0559-2024. Quantity affected: 3,552 bottles.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.